ORMP vs PG · rev $1.3M vs P/E 25, rev $84.28B
Oramed Pharmaceuticals Inc (ORMP) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
ORMP currently screens at market cap $87.2M. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the ORMP and PG stock pages for the full models.
Not investment advice.